Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-119P (RNA, U1 small nuclear 119, pseudogene) is a human pseudogene related to the U1 small nuclear RNA gene family. U1 snRNAs are critical components of the spliceosome complex and are essential for accurate pre-mRNA splicing and transcriptome regulation, but pseudogenes like RNU1-119P lack the necessary sequences for expression or functional incorporation into spliceosomal complexes. While the broader U1 snRNA family is functionally involved in important cell regulatory processes, RNU1-119P itself is not known to be biologically active and is generally not transcribed or translated. RNU1-119P may be annotated due to its sequence similarity but does not appear to play a role in therapeutic targeting or disease pathogenesis.
None. As a pseudogene, RNU1-119P does not have mechanisms of action relevant for drug targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 119, pseudogene (RNU1-119P).